Package 0310-6205-30

{"route": ["ORAL"], "spl_id": "eed62fae-225f-4a73-b778-fe2bbdb3656a", "openfda": {"unii": ["887K2391VH"], "rxcui": ["1486977", "1486981", "1488569", "1488574"], "spl_set_id": ["72ad22ae-efe6-4cd6-a302-98aaee423d69"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-6205-30)", "package_ndc": "0310-6205-30", "marketing_start_date": "20150202"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-6205-90)", "package_ndc": "0310-6205-90", "marketing_start_date": "20240318"}, {"sample": true, "description": "1 BLISTER PACK in 1 CARTON (0310-6205-95)  / 7 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0310-6205-95", "marketing_start_date": "20150202"}], "brand_name": "FARXIGA", "product_id": "0310-6205_eed62fae-225f-4a73-b778-fe2bbdb3656a", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "0310-6205", "generic_name": "DAPAGLIFLOZIN", "labeler_name": "AstraZeneca Pharmaceuticals LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FARXIGA", "active_ingredients": [{"name": "DAPAGLIFLOZIN PROPANEDIOL", "strength": "5 mg/1"}], "application_number": "NDA202293", "marketing_category": "NDA", "marketing_start_date": "20080114", "listing_expiration_date": "20261231"}